KU Researchers Studying Possible Link Between Diabetes and Alzheimer’s Disease

Can influencing the body’s metabolism improve the brain’s energy and how well it functions? Researchers at the University of Kansas Alzheimer’s Disease Center are trying to answer this fundamental question with a new clinical trial involving individuals with Alzheimer’s disease and dapagliflozin, a drug used to treat diabetes. Read more…